June 30, 2020 / 9:31 PM / 8 days ago

BRIEF-Y-mAbs Announces Initiation Of Submission Of Omburtamab Rolling Biologics License Application To FDA

June 30 (Reuters) - Y-mAbs Therapeutics, Inc:

* Y-MABS ANNOUNCES INITIATION OF SUBMISSION OF OMBURTAMAB ROLLING BIOLOGICS LICENSE APPLICATION TO THE FDA

* Y-MABS THERAPEUTICS, - EXPECTS TO PRESENT RESULTS OF PHASE 2 STUDIES 101 AND 03-133 LATER THIS YEAR Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below